Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Asset Utilization Ratio (2016 - 2026)

United Therapeutics' Asset Utilization Ratio history spans 16 years, with the latest figure at 0.42 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 5.21% to 0.42 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.42, a 5.21% increase, with the full-year FY2025 number at 0.42, up 5.44% from a year prior.
  • Asset Utilization Ratio hit 0.42 in Q4 2025 for United Therapeutics, up from 0.41 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for UTHR hit a ceiling of 0.42 in Q4 2025 and a floor of 0.32 in Q1 2023.
  • Historically, Asset Utilization Ratio has averaged 0.36 across 5 years, with a median of 0.33 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: dropped 10.44% in 2021 and later increased 23.76% in 2024.
  • Tracing UTHR's Asset Utilization Ratio over 5 years: stood at 0.33 in 2021, then dropped by 0.74% to 0.33 in 2022, then grew by 0.17% to 0.33 in 2023, then increased by 21.1% to 0.4 in 2024, then grew by 5.21% to 0.42 in 2025.
  • Business Quant data shows Asset Utilization Ratio for UTHR at 0.42 in Q4 2025, 0.41 in Q3 2025, and 0.39 in Q2 2025.